Phone: 614/488-2118
Fax: 614/488-2647

1335 Dublin Rd., Suite 124A
Columbus, OH 43215
Enter your search term

Protocol Categories

View All Protocols


Hematology

ECOG EAA173
Daratumumab to Enhance Therapeutic Effectiveness of Revlimid in Smoldering Myeloma (DETER-SMM)
ECOG EAA181
Effective Quadruplet Utilization After Treatment Evaluation (EQUATE): A Randomized Phase 3 Trial for Newly Diagnosed Multiple Myeloma Not Intended for Early Autologous Transplantation
OSU 20250527-2010C0126 Buckeye Surveillance
Buckeye Surveillance, Contact, and Research for MGUS, Myeloma and AL Amyloidosis
SWOG S1925
Randomized, Phase III Study of Early Intervention with Venetoclax and Obinutuzumab Versus Delayed Therapy with Venetoclax and Obinutuzumab in Newly Diagnosed Asymptomatic High-Risk Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): EVOLVE CLL/SLL Study
Columbus NCORP & NCI Community Oncology Research Program

Our Organization

About
Cancer Resources & Information
Events
Employment
Contact
Sitemap

Members

Protocol Database
Index of Forms
User Profile
Member Sign In
Columbus NCORP & NCI Community Oncology Research Program
© Copyright 2026 Columbus NCI Community Clinical Oncology Research Program. All Rights Reserved.
Site crafted by Robintek: Columbus Website Design